Pathogenicity and virulence of Burkholderia pseudomallei

References

• Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005;18(2):1945–1965.
   Web of Science ®Google Scholar
• Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016;1:15008.
   Web of Science ®Google Scholar
• Choy JL, Mayo M, Janmaat A, et al. Animal melioidosis in Australia. Acta Trop. 2000;74(2–3):153–158.
   PubMed Web of Science ®Google Scholar
• Limmathurotsakul D, Thammasart S, Warrasuth N, et al. Melioidosis in animals, Thailand, 2006–2010. Emerg Infect Dis. 2012;18(2):325.
   PubMed Web of Science ®Google Scholar
• Webb JR, Rachlin A, Rigas V, et al. Tracing the environmental footprint of the Burkholderia pseudomallei lipopolysaccharide genotypes in the tropical “Top End” of the Northern Territory, Australia. PLoS Negl Trop Dis. 2019;13(7):e0007369.
   PubMed Web of Science ®Google Scholar
• Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg. 2010;82(6):1113.
   PubMed Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
   PubMed Web of Science ®Google Scholar
• Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2022;183:109118.
   PubMed Web of Science ®Google Scholar
• Tourism Highlights U. International tourism trends 2017. 2018.
   Google Scholar
• Yabuuchi E, Kosako Y, Oyaizu H, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol. 1992;36(12):1251–1275.
   PubMed Web of Science ®Google Scholar
• Mannaa M, Park I, Seo Y-S. Genomic features and insights into the taxonomy, virulence, and benevolence of plant-associated Burkholderia species. Int J Mol Sci. 2019;20(1):121.
   Web of Science ®Google Scholar
• Coenye T, Vandamme P. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol. 2003;5(9):719–729.
   PubMed Web of Science ®Google Scholar
• Ballard R, Palleroni N, Doudoroff M, et al. Taxonomy of the aerobic pseudomonads: Pseudomonas cepacia, P. marginata, P. alliicola and P. caryophylli. Microbiology. 1970;60(2):199–214.
   Google Scholar
• Urakami T, Ito-Yoshida C, Araki H, et al. Transfer of Pseudomonas plantarii and Pseudomonas glumae to Burkholderia as Burkholderia spp. and description of Burkholderia vandii sp. nov. Int J Syst Evol Microbiol. 1994;44(2):235–245.
   Google Scholar
• Palleroni N, Krieg N, Holt J. Bergey’s manual of systematic bacteriology. Baltimore: The Willian and Wilkins Co; 1984.
   Google Scholar
• Goto K. New bacterial diseases of rice-bacterial brown stripe and bacterial grain rot. Ann Phytopathol Soc Jpn. 1956;21:46–47.
   Google Scholar
• Beukes CW, Palmer M, Manyaka P, et al. Genome data provides high support for generic boundaries in Burkholderia Sensu Lato. Front Microbiol. 2017;8.
   PubMed Web of Science ®Google Scholar
• Hall CM, Baker AL, Sahl JW, et al. Expanding the Burkholderia pseudomallei complex with the addition of two novel species: Burkholderia mayonis sp. nov. and Burkholderia savannae sp. nov. Appl Environ Microbiol. 2021;88(1):e01583–21.
   PubMed Web of Science ®Google Scholar
• Sousa SA, Feliciano JR, Pita T, et al. Burkholderia cepacia complex regulation of virulence gene expression: a review. Genes (Basel). 2017;8(1):43.
   PubMed Web of Science ®Google Scholar
• Somprasong N, Yi J, Hall CM, et al. Conservation of resistance-nodulation-cell division efflux pump-mediated antibiotic resistance in Burkholderia cepacia complex and Burkholderia pseudomallei complex species. Antimicrob Agents Chemother. 2021;65(9):e00920–21.
   PubMed Web of Science ®Google Scholar
• LiPuma JJ. Update on the Burkholderia cepacia complex. Curr Opin Pulm Med. 2005;11(6):528–533.
   PubMed Web of Science ®Google Scholar
• Pegues CF, Pegues DA, Ford DS, et al. Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak. Epidemiol Infect. 1996;116(3):309–317.
   PubMed Web of Science ®Google Scholar
• Lord R, Jones AM, Horsley A. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Cochrane Database Syst Rev. 2020;2020(4). DOI:10.1002/14651858.CD009529.pub4.
   PubMedGoogle Scholar
• Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984;104(2):206–210.
   PubMed Web of Science ®Google Scholar
• Leitão JH, Sousa SA, Ferreira AS, et al. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species. Appl Microbiol Biotechnol. 2010;87(1):31–40.
   PubMed Web of Science ®Google Scholar
• Trust U. Antibiotic treatment for cystic fibrosis. UK Cystic Fibrosis Trust Antibiotic Working Group; 2009.
   Google Scholar
• Sahl JW, Vazquez AJ, Hall CM, et al. The effects of signal erosion and core genome reduction on the identification of diagnostic markers. MBio. 2016;7(5):e00846–16.
   PubMed Web of Science ®Google Scholar
• Whitmore A. An account of a glanders-like disease occurring in Rangoon. Epidemiol Infect. 1913;13(1):1–34.
   Google Scholar
• Whitlock GC, Mark Estes D, Torres AG. Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett. 2007;277(2):115–122.
   PubMed Web of Science ®Google Scholar
• Brett P, Deshazer D, Woods D. Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect. 1997;118(2):137–148.
   PubMed Web of Science ®Google Scholar
• Brett PJ, DeShazer D, Woods DE. Note: Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Evol Microbiol. 1998;48(1):317–320.
   Google Scholar
• Chosewood LC, Wilson DE. Biosafety in microbiological and biomedical laboratories. US Department of Health and Human Services, Public Health Service, Centers of Disease Control and Prevention, National Institutes of Health ; 2009.
   Google Scholar
• Van Zandt KE, Greer MT, Gelhaus HC. Glanders: an overview of infection in humans. Orphanet J Rare Dis. 2013;8(1):1–7.
   PubMedGoogle Scholar
• Elschner MC, Neubauer H, Sprague LD. The resurrection of glanders in a new epidemiological scenario: a beneficiary of “global change”. Curr Clin Microbiol Repo. 2017;4(1):54–60.
   Web of Science ®Google Scholar
• Galyov EE, Brett PJ, DeShazer D. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol. 2010;64:495–517.
   PubMed Web of Science ®Google Scholar
• Godoy D, Randle G, Simpson AJ, et al. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol. 2003;41(5):2068–2079.
   PubMed Web of Science ®Google Scholar
• Nierman WC, DeShazer D, Kim HS, et al. Structural flexibility in the Burkholderia mallei genome. Proc Nat Acad Sci. 2004;101(39):14246–14251.
   PubMed Web of Science ®Google Scholar
• Dance DA. Melioidosis as an emerging global problem. Acta Trop. 2000;74(2–3):115–119.
   PubMed Web of Science ®Google Scholar
• Le Tohic S, Montana M, Koch L, et al. A review of melioidosis cases imported into Europe. Eur J Clin Microbiol Infect Dis. 2019;38(8):1395–1408.
   PubMed Web of Science ®Google Scholar
• Aardema H, Luijnenburg EM, Salm EF, et al. Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil. Epidemiol Infect. 2005;133(5):871–875.
   PubMed Web of Science ®Google Scholar
• Benoit TJ, Blaney DD, Gee JE, et al. Melioidosis cases and selected reports of occupational exposures to Burkholderia pseudomallei—United States, 2008–2013. Morbidity Mortality Weekly Rep. 2015;64(5):1–9.
   PubMed Web of Science ®Google Scholar
• Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J. 2003;22(3):542–550.
   PubMed Web of Science ®Google Scholar
• Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4(11):e900.
   PubMed Web of Science ®Google Scholar
• Dance D. Melioidosis: the tip of the iceberg? Clin Microbiol Rev. 1991;4(1):52–60.
   PubMed Web of Science ®Google Scholar
• Dance DA, Luangraj M, Rattanavong S, et al. Melioidosis in the Lao People’s Democratic Republic. Trop Med Infect Dis. 2018;3(1):21.
   PubMedGoogle Scholar
• Parameswaran U, Baird RW, Ward LM, et al. Melioidosis at Royal Darwin Hospital in the big 2009–2010 wet season: comparison with the preceding 20 years. Med J Aust. 2012;196(5):345–348.
   PubMed Web of Science ®Google Scholar
• Birnie E, Virk HS, Savelkoel J, et al. Global burden of melioidosis in 2015: a systematic review and data synthesis. Lancet Infect Dis. 2019;19(8):892–902.
   PubMed Web of Science ®Google Scholar
• World Health O. Global health estimates: leading causes of DALYs. World Health Organization Retrieved. 2021;23.
   Google Scholar
• Limmathurotsakul D, Chaowagul W, Chierakul W, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis. 2006;43(8):979–986.
   PubMed Web of Science ®Google Scholar
• Yee K, Lee M, Chua C, et al. Melioidosis, the great mimicker: a report of 10 cases from Malaysia. J Trop Med Hyg. 1988;91(5):249–254.
   PubMed Web of Science ®Google Scholar
• White N. Melioidosis. Lancet. 2003;361(9370):1715–1722.
   PubMed Web of Science ®Google Scholar
• Meumann EM, Cheng AC, Ward L, et al. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clinl Infect Dis. 2012;54(3):362–369.
   PubMed Web of Science ®Google Scholar
• Churuangsuk C, Chusri S, Hortiwakul T, et al. Characteristics, clinical outcomes and factors influencing mortality of patients with melioidosis in southern Thailand: a 10-year retrospective study. Asian Pac J Trop Med. 2016;9(3):256–260.
   PubMed Web of Science ®Google Scholar
• In: Currie BJ, editor. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. In: Seminars in respiratory and critical care medicine . Thieme Medical Publishers; 2015;36(01):111–125.
   Google Scholar
• Garg R, Shaw T, Vandana KE, et al. Melioidosis in suspected recurrent tuberculosis: a disease in disguise. J Infect Developing Countries. 2020;14(03):312–316.
   Google Scholar
• Lipsitz R, Garges S, Aurigemma R, et al. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei infection, 2010. Emerg Infect Dis. 2012;18(12):e2.
   PubMedGoogle Scholar
• Dance D. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents. 2014;43(4):310–318.
   PubMed Web of Science ®Google Scholar
• Cheng AC, Fisher DA, Anstey NM, et al. Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother. 2004;48(5):1763–1765.
   PubMed Web of Science ®Google Scholar
• Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clinl Infect Dis. 2000;31(4):981–986.
   PubMed Web of Science ®Google Scholar
• Chusri S, Hortiwakul T, Charoenmak B, et al. Outcomes of patients with melioidosis treated with cotrimoxazole alone for eradication therapy. Am J Trop Med Hyg. 2012;87(5):927–932.
   PubMed Web of Science ®Google Scholar
• Chetchotisakd P, Chierakul W, Chaowagul W, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383(9919):807–814.
   PubMed Web of Science ®Google Scholar
• Fisher DA, Harris PN. Melioidosis: refining management of a tropical time bomb. Lancet. 2014;383(9919):762–764.
   PubMed Web of Science ®Google Scholar
• Holden MT, Titball RW, Peacock SJ, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A. 2004;101(39):14240–14245.
   PubMed Web of Science ®Google Scholar
• Schweizer HP. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiol. 2012;7(12):1389–1399.
   PubMed Web of Science ®Google Scholar
• Chomkatekaew C, Boonklang P, Sangphukieo A, et al. An evolutionary arms race between Burkholderia pseudomallei and host immune system: what do we know? Front Microbiol. 2021;11. DOI:10.3389/fmicb.2020.612568.
   Web of Science ®Google Scholar
• Jones AL, Beveridge TJ, Woods DE. Intracellular survival of Burkholderia pseudomallei. Infect Immun. 1996;64(3):782–790.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012;367(11):1035–1044.
   PubMed Web of Science ®Google Scholar
• Katz M, Smith S, Conway L, et al. Melioidosis in a patient with type 1 diabetes mellitus on an insulin pump. Endocrinol Diabetes Metab Case Rep. 2018;2018. DOI:10.1530/EDM-18-0062.
   PubMedGoogle Scholar
• Soffler C, Bosco-Lauth AM, Aboellail TA, et al. Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis. Int J Exp Pathol. 2014;95(2):101–119.
   PubMed Web of Science ®Google Scholar
• Bodilsen J, Langgaard H, Nielsen HL. Cutaneous melioidosis in a healthy Danish man after travelling to South-East Asia. BMJ Case Rep. 2015;2015. DOI:10.1136/bcr-2014-207340.
   PubMedGoogle Scholar
• Thomas RJ, Davies C, Nunez A, et al. Particle-size dependent effects in the BALB/c murine model of inhalational melioidosis. Front Cell Infect Microbiol. 2012;2:101.
   PubMed Web of Science ®Google Scholar
• Thomas RJ. Particle size and pathogenicity in the respiratory tract. Virulence. 2013;4(8):847–858.
   PubMed Web of Science ®Google Scholar
• Tan G-Y, Liu Y, Sivalingam SP, et al. Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice. J Med Microbiol. 2008;57(4):508–515.
   PubMed Web of Science ®Google Scholar
• Craig L, Forest KT, Maier B. Type IV pili: dynamics, biophysics and functional consequences. Nature Rev Microbiol. 2019;17(7):429–440.
   PubMed Web of Science ®Google Scholar
• Essex-Lopresti AE, Boddey JA, Thomas R, et al. A type IV pilin, PilA, contributes to adherence of Burkholderia pseudomallei and virulence in vivo. Infect Immun. 2005;73(2):1260–1264.
   PubMed Web of Science ®Google Scholar
• Boddey JA, Flegg CP, Day CJ, et al. Temperature-regulated microcolony formation by Burkholderia pseudomallei requires pilA and enhances association with cultured human cells. Infect Immun. 2006;74(9):5374–5381.
   PubMed Web of Science ®Google Scholar
• Nandi T, Holden MTG, Didelot X, et al. Burkholderia pseudomallei sequencing identifies genomic clades with distinct recombination, accessory, and epigenetic profiles. Genome Res. 2015;25(1):129–141.
   PubMed Web of Science ®Google Scholar
• Okaro U, Mou S, Lenkoue G, et al. A type IVB pilin influences twitching motility and in vitro adhesion to epithelial cells in Burkholderia pseudomallei. Microbiology. 2022;168(3):001150.
   PubMed Web of Science ®Google Scholar
• Avalos Vizcarra I, Hosseini V, Kollmannsberger P, et al. How type 1 fimbriae help Escherichia coli to evade extracellular antibiotics. Sci Rep. 2016;6(1):1–13.
   PubMedGoogle Scholar
• Sanchez-Villamil JI, Tapia D, Borlee GI, et al. Burkholderia pseudomallei as an enteric pathogen: identification of virulence factors mediating gastrointestinal infection. Infect Immun. 2020;89(1):e00654–20.
   PubMed Web of Science ®Google Scholar
• Adler NRL, Stevens JM, Stevens MP, et al. Autotransporters and their role in the virulence of Burkholderia pseudomallei and Burkholderia mallei. Front Microbiol. 2011;2:151.
   PubMed Web of Science ®Google Scholar
• Balder R, Lipski S, Lazarus JJ, et al. Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells. BMC Microbiol. 2010;10(1):1–19.
   PubMedGoogle Scholar
• Campos CG, Byrd MS, Cotter PA. Functional characterization of Burkholderia pseudomallei trimeric autotransporters. Infect Immun. 2013;81(8):2788–2799.
   PubMed Web of Science ®Google Scholar
• Lafontaine ER, Balder R, Michel F, et al. Characterization of an autotransporter adhesin protein shared by Burkholderia mallei and Burkholderia pseudomallei. BMC Microbiol. 2014;14(1):1–14.
   Google Scholar
• Campos CG, Borst L, Cotter PA. Characterization of BcaA, a putative classical autotransporter protein in Burkholderia pseudomallei. Infect Immun. 2013;81(4):1121–1128.
   PubMed Web of Science ®Google Scholar
• Chua KL, Chan YY, Gan YH. Flagella are virulence determinants of Burkholderia pseudomallei. Infect Immun. 2003;71(4):1622–1629.
   PubMed Web of Science ®Google Scholar
• Chuaygud T, Tungpradabkul S, Sirisinha S, et al. A role of Burkholderia pseudomallei flagella as a virulent factor. Trans R Soc Trop Med Hyg. 2008;102 Suppl 1:S140–4.
   PubMed Web of Science ®Google Scholar
• DeShazer D, Brett PJ, Carlyon R, et al. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol. 1997;179(7):2116–2125.
   PubMed Web of Science ®Google Scholar
• Wikraiphat C, Charoensap J, Utaisincharoen P, et al. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants. FEMS Immunol Med Microbiol. 2009;56(3):253–259.
   PubMedGoogle Scholar
• Brett PJ, Mah D, Woods DE. Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun. 1994;62(5):1914–1919.
   PubMed Web of Science ®Google Scholar
• Inglis TJJ, Robertson T, Woods DE, et al. Flagellum-mediated adhesion by Burkholderia pseudomallei precedes invasion of Acanthamoeba astronyxis. Infect Immun. 2003;71(4):2280–2282.
   PubMed Web of Science ®Google Scholar
• Tuanyok A, Auerbach RK, Brettin TS, et al. A horizontal gene transfer event defines two distinct groups within Burkholderia pseudomallei that have dissimilar geographic distributions. J Bacteriol. 2007;189(24):9044–9049.
   PubMed Web of Science ®Google Scholar
• French CT, Toesca IJ, Wu T-H, et al. Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc Nat Acad Sci. 2011;108(29):12095–12100.
   PubMed Web of Science ®Google Scholar
• Maloy JP. Characterization of an intracellular flagellar system in pathogenic Burkholderia. Species: University of California; 2017.
   Google Scholar
• Koosakulnirand S, Phokrai P, Jenjaroen K, et al. Immune response to recombinant Burkholderia pseudomallei FliC. PLoS One. 2018;13(6):e0198906.
   PubMed Web of Science ®Google Scholar
• Amemiya K, Dankmeyer JL, Bernhards RC, et al. Activation of toll-like receptors by live gram-negative bacterial pathogens reveals mitigation of TLR4 responses and activation of TLR5 by Flagella. Front Cell Infect Microbiol. 2021;11:1089.
   Web of Science ®Google Scholar
• Reckseidler-Zenteno SL, Viteri D-F, Moore R, et al. Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei. J Med Microbiol. 2010;59(12):1403–1414.
   PubMed Web of Science ®Google Scholar
• Perry MB, MacLean LL, Schollaardt T, et al. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun. 1995;63(9):3348–3352.
   PubMed Web of Science ®Google Scholar
• Reckseidler SL, DeShazer D, Sokol PA, et al. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun. 2001;69(1):34–44.
   PubMed Web of Science ®Google Scholar
• Reckseidler-Zenteno SL, DeVinney R, Woods DE. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun. 2005;73(2):1106–1115.
   PubMed Web of Science ®Google Scholar
• Cuccui J, Milne TS, Harmer N, et al. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region. Infect Immun. 2012;80(3):1209–1221.
   PubMed Web of Science ®Google Scholar
• DeShazer D, Brett PJ, Woods DE. The type II O‐antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol. 1998;30(5):1081–1100.
   PubMed Web of Science ®Google Scholar
• Sarkar-Tyson M, Thwaite J, Harding S, et al. Polysaccharides and virulence of Burkholderia pseudomallei. J Med Microbiol. 2007;56(8):1005–1010.
   PubMed Web of Science ®Google Scholar
• Knirel YA, Paramonov NA, Shashkov AS, et al. Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharides. Carbohydr Res. 1992;233:185–193.
   PubMed Web of Science ®Google Scholar
• Nimtz M, Wray V, Domke T, et al. Structure of an acidic exopolysaccharide of Burkholderia pseudomallei. Eur J Biochem. 1997;250(2):608–616.
   PubMedGoogle Scholar
• Masoud H, Ho M, Schollaardt T, et al. Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b. J Bacteriol. 1997;179(18):5663–5669.
   PubMed Web of Science ®Google Scholar
• Burtnick MN, Heiss C, Roberts RA, et al. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Front Cell Infect Microbiol. 2012;2:108.
   PubMed Web of Science ®Google Scholar
• Atkins T, Prior R, Mack K, et al. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J Med Microbiol. 2002;51(7):539–553.
   PubMed Web of Science ®Google Scholar
• Warawa JM, Long D, Rosenke R, et al. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis. Infect Immun. 2009;77(12):5252–5261.
   PubMed Web of Science ®Google Scholar
• Sperandeo P, Dehò G, Polissi A. The lipopolysaccharide transport system of gram-negative bacteria. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids. 2009;1791(7):594–602.
   PubMed Web of Science ®Google Scholar
• Anuntagool N, Wuthiekanun V, White NJ, et al. Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg. 2006;74(3):348–352.
   PubMed Web of Science ®Google Scholar
• Tuanyok A, Stone JK, Mayo M, et al. The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. PLoS Negl Trop Dis. 2012;6(1):e1453.
   PubMed Web of Science ®Google Scholar
• Arjcharoen S, Wikraiphat C, Pudla M, et al. Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival. Infect Immun. 2007;75(9):4298–4304.
   PubMed Web of Science ®Google Scholar
• Beutler B, Hoebe K, Du X, et al. How we detect microbes and respond to them: the Toll‐like receptors and their transducers. J Leukoc Biol. 2003;74(4):479–485.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Wieland CW, Dessing MC, et al. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med. 2007;4(7):e248.
   PubMed Web of Science ®Google Scholar
• Sengyee S, Yoon SH, Paksanont S, et al. Comprehensive analysis of clinical Burkholderia pseudomallei isolates demonstrates conservation of unique lipid a structure and TLR4-dependent innate immune activation. PLoS Negl Trop Dis. 2018;12(2):e0006287.
   PubMed Web of Science ®Google Scholar
• Weehuizen TA, Prior JL, van der Vaart TW, et al. Differential Toll-like receptor-signalling of Burkholderia pseudomallei lipopolysaccharide in murine and human models. PLoS One. 2015;10(12):e0145397.
   PubMed Web of Science ®Google Scholar
• Bogdan C, Röllinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol. 2000;12(1):64–76.
   PubMed Web of Science ®Google Scholar
• Utaisincharoen P, Anuntagool N, Limposuwan K, et al. Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages. Infect Immun. 2003;71(6):3053–3057.
   PubMed Web of Science ®Google Scholar
• MacMicking J, Xie Q-W, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15(1):323–350.
   PubMedGoogle Scholar
• Utaisincharoen P, Tangthawornchaikul N, Kespichayawattana W, et al. Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing. Microbiol Immunol. 2001;45(4):307–313.
   PubMed Web of Science ®Google Scholar
• Miyagi K, Kawakami K, Saito A. Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect Immun. 1997;65(10):4108–4113.
   PubMed Web of Science ®Google Scholar
• Subsin B, Thomas MS, Katzenmeier G, et al. Role of the stationary growth phase sigma factor RpoS of Burkholderia pseudomallei in response to physiological stress conditions. J Bacteriol. 2003;185(23):7008–7014.
   PubMed Web of Science ®Google Scholar
• Utaisincharoen P, Arjcharoen S, Limposuwan K, et al. Burkholderia pseudomallei RpoS regulates multinucleated giant cell formation and inducible nitric oxide synthase expression in mouse macrophage cell line (RAW 264.7). Microb Pathog. 2006;40(4):184–189.
   PubMed Web of Science ®Google Scholar
• Chutoam P, Charoensawan V, Wongtrakoongate P, et al. RpoS and oxidative stress conditions regulate succinyl-CoA: 3-ketoacid-coenzyme a transferase (SCOT) expression in Burkholderia pseudomallei. Microbiol Immunol. 2013;57(9):605–615.
   PubMed Web of Science ®Google Scholar
• Korbsrisate S, Vanaporn M, Kerdsuk P, et al. The Burkholderia pseudomallei RpoE (AlgU) operon is involved in environmental stress tolerance and biofilm formation. FEMS Microbiol Lett. 2005;252(2):243–249.
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V, Vanaporn M, Songtawee N, et al. Altered proteome in Burkholderia pseudomallei rpoE operon knockout mutant: insights into mechanisms of rpoE operon in stress tolerance, survival, and virulence. J Proteome Res. 2007;6(4):1334–1341.
   PubMed Web of Science ®Google Scholar
• Loprasert S, Sallabhan R, Whangsuk W, et al. The Burkholderia pseudomallei oxyR gene: expression analysis and mutant characterization. Gene. 2002;296(1–2):161–169.
   PubMed Web of Science ®Google Scholar
• Loprasert S, Whangsuk W, Sallabhan R, et al. Regulation of the katG‐dpsA operon and the importance of KatG in survival of Burkholderia pseudomallei exposed to oxidative stress. FEBS Lett. 2003;542(1–3):17–21.
   PubMed Web of Science ®Google Scholar
• Jangiam W, Loprasert S, Smith DR, et al. Burkholderia pseudomallei RpoS regulates OxyR and the katG‐dpsA operon under conditions of oxidative stress. Microbiol Immunol. 2010;54(7):389–397.
   PubMed Web of Science ®Google Scholar
• Loprasert S, Sallabhan R, Whangsuk W, et al. Compensatory increase in ahpC gene expression and its role in protecting Burkholderia pseudomallei against reactive nitrogen intermediates. Arch Microbiol. 2003;180(6):498–502.
   PubMed Web of Science ®Google Scholar
• Loprasert S, Whangsuk W, Sallabhan R, et al. DpsA protects the human pathogen Burkholderia pseudomallei against organic hydroperoxide. Arch Microbiol. 2004;182(1):96–101.
   PubMed Web of Science ®Google Scholar
• Ha HC, Sirisoma NS, Kuppusamy P, et al. The natural polyamine spermine functions directly as a free radical scavenger. Proc Nat Acad Sci. 1998;95(19):11140–11145.
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64(1):97–112.
   PubMedGoogle Scholar
• Vanaporn M, Wand M, Michell SL, et al. Superoxide dismutase C is required for intracellular survival and virulence of Burkholderia pseudomallei. Microbiology. 2011;157(8):2392–2400.
   PubMedGoogle Scholar
• Harley V, Dance D, Drasar B, et al. Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios. 1998;96(384):71–93.
   PubMedGoogle Scholar
• Harley V, Dance D, Tovey G, et al. An ultrastructural study of the phagocytosis of Burkholderia pseudomallei. Microbios. 1998;94(377):35–45.
   PubMedGoogle Scholar
• Rainbow L, Hart CA, Winstanley C. Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei. J Med Microbiol. 2002;51(5):374–384.
   PubMed Web of Science ®Google Scholar
• Winstanley C, Hales B, Hart C. Evidence for the presence in Burkholderia pseudomallei of a type III secretion system-associated gene cluster. J Med Microbiol. 1999;48(7):649–656.
   PubMed Web of Science ®Google Scholar
• Attree O, Attree I. A second type III secretion system in Burkholderia pseudomallei: who is the real culprit? Microbiology. 2001;147(12):3197–3199.
   PubMedGoogle Scholar
• Stevens MP, Wood MW, Taylor LA, et al. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol Microbiol. 2002;46(3):649–659.
   PubMed Web of Science ®Google Scholar
• Burtnick MN, Brett PJ, Nair V, et al. Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Infect Immun. 2008;76(7):2991–3000.
   PubMed Web of Science ®Google Scholar
• Muangsombut V, Suparak S, Pumirat P, et al. Inactivation of Burkholderia pseudomallei bsaQ results in decreased invasion efficiency and delayed escape of bacteria from endocytic vesicles. Arch Microbiol. 2008;190(6):623–631.
   PubMed Web of Science ®Google Scholar
• Kubori T, Sukhan A, Aizawa S-I, et al. Molecular characterization and assembly of the needle complex of the Salmonella Typhimurium type III protein secretion system. Proc Nat Acad Sci. 2000;97(18):10225–10230.
   PubMed Web of Science ®Google Scholar
• Pilatz S, Breitbach K, Hein N, et al. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun. 2006;74(6):3576–3586.
   PubMed Web of Science ®Google Scholar
• Stevens MP, Friebel A, Taylor LA, et al. A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity. J Bacteriol. 2003;185(16):4992–4996.
   PubMed Web of Science ®Google Scholar
• Srinon V, Muangman S, Imyaem N, et al. Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant. J Microbiol. 2013;51(4):522–526.
   PubMed Web of Science ®Google Scholar
• Kang W-T, Vellasamy KM, Chua E-G, et al. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis. J Infect Dis. 2015;211(5):827–834.
   PubMed Web of Science ®Google Scholar
• Suparak S, Kespichayawattana W, Haque A, et al. Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB. J Bacteriol. 2005;187(18):6556–6560.
   PubMed Web of Science ®Google Scholar
• Muangman S, Korbsrisate S, Muangsombut V, et al. BopC is a type III secreted effector protein of Burkholderia pseudomallei. FEMS Microbiol Lett. 2011;323(1):75–82.
   PubMed Web of Science ®Google Scholar
• Cullinane M, Gong L, Li X, et al. Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell lines. Autophagy. 2008;4(6):744–753.
   PubMed Web of Science ®Google Scholar
• Yao Q, Cui J, Zhu Y, et al. A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc Nat Acad Sci. 2009;106(10):3716–3721.
   PubMed Web of Science ®Google Scholar
• Cui J, Yao Q, Li S, et al. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science. 2010;329(5996):1215–1218.
   PubMed Web of Science ®Google Scholar
• Yao Q, Cui J, Wang J, et al. Structural mechanism of ubiquitin and NEDD8 deamidation catalyzed by bacterial effectors that induce macrophage-specific apoptosis. Proc Nat Acad Sci. 2012;109(50):20395–20400.
   PubMed Web of Science ®Google Scholar
• Gong L, Lai S-C, Treerat P, et al. Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS, a chemotherapeutic target for small-molecule ATPase inhibitors. Infect Immun. 2015;83(4):1276–1285.
   PubMed Web of Science ®Google Scholar
• Sinha AK, Dutta A, Chandravanshi M, et al. An insight into bacterial phospholipase C classification and their translocation through Tat and Sec pathways: a data mining study. Meta Gene. 2019;20:100547.
   Web of Science ®Google Scholar
• Korbsrisate S, Tomaras AP, Damnin S, et al. Characterization of two distinct phospholipase C enzymes from Burkholderia pseudomallei. Microbiology. 2007;153(6):1907–1915.
   PubMedGoogle Scholar
• Srinon V, Withatanung P, Chaiwattanarungruengpaisan S, et al. Functional redundancy of Burkholderia pseudomallei phospholipase C enzymes and their role in virulence. Sci Rep. 2020;10(1):1–12.
   PubMed Web of Science ®Google Scholar
• Houghton AM, Hartzell WO, Robbins CS, et al. Macrophage elastase kills bacteria within murine macrophages. Nature. 2009;460(7255):637–641.
   PubMed Web of Science ®Google Scholar
• Ireland PM, Marshall L, Norville I, et al. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei. Microb Pathog. 2014;67:55–58.
   PubMed Web of Science ®Google Scholar
• Nagy ZA, Szakács D, Boros E, et al. Ecotin, a microbial inhibitor of serine proteases, blocks multiple complement dependent and independent microbicidal activities of human serum. PLoS Pathog. 2019;15(12):e1008232.
   PubMed Web of Science ®Google Scholar
• Norris MH, Propst KL, Kang Y, et al. The Burkholderia pseudomallei δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Infect Immun. 2011;79(10):4010–4018.
   PubMed Web of Science ®Google Scholar
• Atkins T, Prior RG, Mack K, et al. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun. 2002;70(9):5290–5294.
   PubMed Web of Science ®Google Scholar
• Moule MG, Hemsley CM, Seet Q, et al. Genome-wide saturation mutagenesis of Burkholderia pseudomallei K96243 predicts essential genes and novel targets for antimicrobial development. MBio. 2014;5(1):e00926–13.
   PubMed Web of Science ®Google Scholar
• Tuanyok A, Tom M, Dunbar J, et al. Genome-wide expression analysis of Burkholderia pseudomallei infection ina hamster model of acute melioidosis. Infect Immun. 2006;74(10):5465–5476.
   PubMed Web of Science ®Google Scholar
• van Schaik EJ, Tom M, Woods DE. Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: implications for the development of isocitrate lyase inhibitors as novel antimicrobials. Infect Immun. 2009;77(10):4275–4283.
   PubMed Web of Science ®Google Scholar
• Cruz-Migoni A, Hautbergue GM, Artymiuk PJ, et al. A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science. 2011;334(6057):821–824.
   PubMed Web of Science ®Google Scholar
• Moule MG, Spink N, Willcocks S, et al. Characterization of new virulence factors involved in the intracellular growth and survival of Burkholderia pseudomallei. Infect Immun. 2015;84(3):701–710.
   PubMed Web of Science ®Google Scholar
• Norville IH, Breitbach K, Eske-Pogodda K, et al. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei. Microbiology. 2011;157(9):2629–2638.
   PubMedGoogle Scholar
• Norville IH, Harmer NJ, Harding SV, et al. A Burkholderia pseudomallei macrophage infectivity potentiator-like protein has rapamycin-inhibitable peptidylprolyl isomerase activity and pleiotropic effects on virulence. Infect Immun. 2011;79(11):4299–4307.
   PubMed Web of Science ®Google Scholar
• Fischer G, Aumüller T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. In: Reviews of physiology, biochemistry and pharmacology. Springer; 2003. p. 105–150.
   Google Scholar
• Kespichayawattana W, Rattanachetkul S, Wanun T, et al. Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun. 2000;68(9):5377–5384.
   PubMed Web of Science ®Google Scholar
• Stevens MP, Stevens JM, Jeng RL, et al. Identification of a bacterial factor required for actin‐based motility of Burkholderia pseudomallei. Mol Microbiol. 2005;56(1):40–53.
   PubMed Web of Science ®Google Scholar
• Breitbach K, Rottner K, Klocke S, et al. Actin‐based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N‐WASP and Ena/VASP proteins. Cell Microbiol. 2003;5(6):385–393.
   PubMed Web of Science ®Google Scholar
• Srinon V, Chaiwattanarungruengpaisan S, Korbsrisate S, et al. Burkholderia pseudomallei BimC is required for actin-based motility, intracellular survival, and virulence. Front Cell Infect Microbiol. 2019;9:63.
   PubMed Web of Science ®Google Scholar
• Wong K, Puthucheary S, Vadivelu J. The histopathology of human melioidosis. Histopathology. 1995;26(1):51–55.
   PubMed Web of Science ®Google Scholar
• Boddey JA, Day CJ, Flegg CP, et al. The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast‐related genes in Burkholderia pseudomallei‐induced TRAP‐positive multinucleated giant cells. Cell Microbiol. 2007;9(2):514–531.
   PubMed Web of Science ®Google Scholar
• Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289(5484):1504–1508.
   PubMed Web of Science ®Google Scholar
• Burtnick MN, Brett PJ, Harding SV, et al. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun. 2011;79(4):1512–1525.
   PubMed Web of Science ®Google Scholar
• Miyata ST, Kitaoka M, Brooks TM, et al. Vibrio cholerae requires the type VI secretion system virulence factor VasX to kill Dictyostelium discoideum. Infect Immun. 2011;79(7):2941–2949.
   PubMed Web of Science ®Google Scholar
• Rigard M, Bröms JE, Mosnier A, et al. Francisella tularensis IglG belongs to a novel family of PAAR-like T6SS proteins and harbors a unique N-terminal extension required for virulence. PLoS Pathog. 2016;12(9):e1005821.
   PubMed Web of Science ®Google Scholar
• Sana TG, Lugo KA, Monack DM. T6SS: the bacterial“fight club” in the host gut. PLoS Pathog. 2017;13(6):e1006325.
   PubMed Web of Science ®Google Scholar
• Toesca IJ, French CT, Miller JF. The Type VI secretion system spike protein VgrG5 mediates membrane fusion during intercellular spread by pseudomallei group Burkholderia species. Infect Immun. 2014;82(4):1436–1444.
   PubMed Web of Science ®Google Scholar
• Schwarz S, Singh P, Robertson JD, et al. VgrG-5 is a Burkholderia type VI secretion system-exported protein required for multinucleated giant cell formation and virulence. Infect Immun. 2014;82(4):1445–1452.
   PubMed Web of Science ®Google Scholar
• Wong J, Chen Y, Gan Y-H. Host cytosolic glutathione sensing by a membrane histidine kinase activates the type VI secretion system in an intracellular bacterium. Cell Host Microbe. 2015;18(1):38–48.
   PubMed Web of Science ®Google Scholar
• Schwarz S, West TE, Boyer F, et al. Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog. 2010;6(8):e1001068.
   PubMed Web of Science ®Google Scholar
• Losada L, Shea AA, DeShazer D. A MarR family transcriptional regulator and subinhibitory antibiotics regulate type VI secretion gene clusters in Burkholderia pseudomallei. Microbiology. 2018;164(9):1196–1211.
   PubMed Web of Science ®Google Scholar
• Si M, Zhao C, Burkinshaw B, et al. Manganese scavenging and oxidative stress response mediated by type VI secretion system in Burkholderia thailandensis. Proc Nat Acad Sci. 2017;114(11):E2233–42.
   PubMed Web of Science ®Google Scholar
• Si M, Wang Y, Zhang B, et al. The type VI secretion system engages a redox-regulated dual-functional heme transporter for zinc acquisition. Cell Rep. 2017;20(4):949–959.
   PubMed Web of Science ®Google Scholar
• Schell MA, Ulrich RL, Ribot WJ, et al. Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol. 2007;64(6):1466–1485.
   PubMed Web of Science ®Google Scholar
• Shalom G, Shaw JG, Thomas MS. In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages. Microbiology. 2007;153(Pt 8):2689–2699.
   PubMedGoogle Scholar
• Silverman JM, Agnello DM, Zheng H, et al. Haemolysin coregulated protein is an exported receptor and chaperone of type VI secretion substrates. Mol Cell. 2013;51(5):584–593.
   PubMed Web of Science ®Google Scholar
• Lim YT, Jobichen C, Wong J, et al. Extended loop region of Hcp1 is critical for the assembly and function of type VI secretion system in Burkholderia pseudomallei. Sci Rep. 2015;5(1):1–10.
   Google Scholar
• Lennings J, West TE, Schwarz S. The Burkholderia type VI secretion system 5: composition, regulation and role in virulence. Front Microbiol. 2019;9:3339.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wong J, Sun GW, et al. Regulation of type VI secretion system during Burkholderia pseudomallei infection. Infect Immun. 2011;79(8):3064–3073.
   PubMed Web of Science ®Google Scholar
• DeShazer D. A novel contact-independent T6SS that maintains redox homeostasis via Zn2+ and Mn2+ acquisition is conserved in the Burkholderia pseudomallei complex. Microbiol Res. 2019;226:48–54.
   PubMedGoogle Scholar
• Bzdyl NM, Scott NE, Norville IH, et al. Peptidyl-Prolyl Isomerase ppiB is essential for Proteome Homeostasis and virulence in Burkholderia pseudomallei. Infect Immun. 2019;87(10):e00528–19.
   PubMed Web of Science ®Google Scholar